Krispy Kreme Doughnut CorporationFDA
- FEI
- 3004794454
- Record date
- Establishment
- Manufacturer
- Location
- Ohio, United States
FDA 483 Database
FDA Form 483s Issued in July 2022
Every published Form FDA 483 issued in July 2022, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
5
Published 483s in July 2022
5
Distinct firms
Form 483s issued in July 2022
- Revance Therapeutics, IncFDA
- FEI
- 3007772056
- Record date
- Establishment
- Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
- Location
- United States
- Valisure, LLCFDA
- FEI
- 3012063246
- Record date
- Establishment
- Bioanalytical Lab
- Location
- Connecticut, United States
- AnazaoHealth CorporationFDA
- FEI
- 3011152407
- Record date
- Establishment
- Outsourcing Facility
- Location
- Nevada, United States
- Cipla LimitedFDA
- FEI
- 3008581988
- Record date
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- India
| Company | FEI | Establishment type | Location | FDA date | Source |
|---|---|---|---|---|---|
| Krispy Kreme Doughnut Corporation | 3004794454 | Manufacturer | Ohio, United States | FDA | |
| Revance Therapeutics, Inc | 3007772056 | Active Pharmaceutical Ingredient & Finished Dosage Manufacturer | United States | FDA | |
| Valisure, LLC | 3012063246 | Bioanalytical Lab | Connecticut, United States | FDA | |
| AnazaoHealth Corporation | 3011152407 | Outsourcing Facility | Nevada, United States | FDA | |
| Cipla Limited | 3008581988 | Finished Pharmaceutical Manufacturer | India | FDA |